Last reviewed · How we verify
Gastrointestinal infection caused by Klebsiella aerogenes
Approved treatments
- Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Gastrointestinal infection caused by Klebsiella aerogenes patent landscape — cliff calendar, originator estates, attackable patents
- Gastrointestinal infection caused by Klebsiella aerogenes treatment landscape brief
- Gastrointestinal infection caused by Klebsiella aerogenes treatment updates RSS
Frequently asked questions about Gastrointestinal infection caused by Klebsiella aerogenes
What drugs treat Gastrointestinal infection caused by Klebsiella aerogenes?
Tracked treatments include Recarbrio.
What is the treatment for Gastrointestinal infection caused by Klebsiella aerogenes?
Standard treatment for Gastrointestinal infection caused by Klebsiella aerogenes includes Recarbrio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Gastrointestinal infection caused by Klebsiella aerogenes patent cliff · Gastrointestinal infection caused by Klebsiella aerogenes CI report
- Treatment: Recarbrio · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing